S100A6 and lung carcinoma: Overexpression of S100A6, driven by miR-193a (117) or by HIF-1-α-induced hypermethylation (118) of the S100A6 promoter region, has been linked to the promotion of lung cancer cell proliferation, invasion, migration, and angiogenesis.